Inventor

FERRARI PATRIZIA

IT30 patents

⚠️ This page may combine multiple inventors who share the name “FERRARI PATRIZIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FERRARI PATRIZIA

SIGMA TAU IND FARMACEUTI

17-(4-pyridazinyl) -5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same

Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders

17-(3-furyl)-5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same

Cyclopentanperhydrophenanthren-17β-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders

Seco-D steroids active on the cardiovascular system and pharmaceutical compositions containing same

Hydrazino and hydroxyamino-14-β-hydroxyandrostane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same

17-iminomethylalkenyl-5 β, 14 β-androstane and 17-iminoalkyl-5 β, 14 β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same

Digitoxigenin and dihydrodigitoxigenin 3β-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders

17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing the same

17-(3-imino-2-alkylpropenyl)-5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same

Therapeutical method for the treatment of hypertension

Seco-d steroids active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them

Hydrazono-5β, 14β-androstane derivatives active on the cardiovascular system, and pharmaceutical compositions containing same

3,9-disubstituted-spiro(5.5)undecanes active on the cardiovascular system, process for their preparation and pharmaceutical composition containing same

1,5-disubstituted 7A-methylperhydroinden-3A-ol derivatives, useful in treating cardiovascular disorders, processes for their preparation and pharmaceutical compositions containing the same

Diterpenoid derivatives endowed of biological properties

Amino derivatives of beta-homoandrostanes and beta-heteroandrostanes

ERBA FARMITALIA

Aminoglycoside steroids, a process for their preparation, their use and pharmaceutical compositions containing them

Aminoglycoside steroids, a process for their preparation, their use and pharmaceutical compositions containing them

Nor-cholanic acid derivatives, a process for their preparation, their use and pharmaceutical compositions containing them

WINDTREE THERAPEUTICS INC

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF)

CERRI ALBERTO

Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders

Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

BIANCHI GIUSEPPE

Methods and systems for pharmacogenomic treatment of cardiovascular conditions

CVIE THERAPEUTICS LTD

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

SIGMA-TAU IND FARMACEUTICHE RIUNITE S P A

5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure

SEISMIC PHARMACEUTICALS

Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure